Potassium triiodide

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Potassium triiodide
Accession Number
DB14492
Description
Not Available
Type
Small Molecule
Groups
Experimental
Structure
Thumb
Weight
Average: 419.8117
Monoisotopic: 419.67712
Chemical Formula
I3K
Synonyms
  • Iodine aqueous
  • Lugol's iodine
  • Lugol's solution
  • Microiodide
  • Potassium triiodide

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcebutololPotassium triiodide may increase the hyperkalemic activities of Acebutolol.
AceclofenacPotassium triiodide may increase the hyperkalemic activities of Aceclofenac.
AcemetacinPotassium triiodide may increase the hyperkalemic activities of Acemetacin.
Acetylsalicylic acidPotassium triiodide may increase the hyperkalemic activities of Acetylsalicylic acid.
AlclofenacPotassium triiodide may increase the hyperkalemic activities of Alclofenac.
AliskirenPotassium triiodide may increase the hyperkalemic activities of Aliskiren.
AmilorideThe risk or severity of hyperkalemia can be increased when Potassium triiodide is combined with Amiloride.
AminophenazonePotassium triiodide may increase the hyperkalemic activities of Aminophenazone.
AmiodaronePotassium triiodide may increase the hyperkalemic activities of Amiodarone.
AmlodipinePotassium triiodide may increase the hyperkalemic activities of Amlodipine.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

Products

International/Other Brands
Lugol's solution
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
CitraNatal 90 DHAPotassium triiodide (150 ug/1) + Ascorbic acid (120 mg/1) + Calcium citrate tetrahydrate (160 mg/1) + Cupric oxide (2 mg/1) + Docusate sodium (50 mg/1) + Folic acid (1 mg/1) + Iron (90 mg/1) + Nicotinamide (20 mg/1) + Pyridoxine hydrochloride (20 mg/1) + Riboprine (3.4 mg/1) + Thiamine chloride (3 mg/1) + Vitamin D (400 [iU]/1) + Zinc oxide (25 mg/1) + alpha-Tocopherol acetate (30 [iU]/1)TabletOralMission Pharmacal2010-02-01Not applicableUs
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
CitraNatal 90 DHAPotassium triiodide (150 ug/1) + Ascorbic acid (120 mg/1) + Calcium citrate tetrahydrate (160 mg/1) + Cupric oxide (2 mg/1) + Docusate sodium (50 mg/1) + Folic acid (1 mg/1) + Iron (90 mg/1) + Nicotinamide (20 mg/1) + Pyridoxine hydrochloride (20 mg/1) + Riboprine (3.4 mg/1) + Thiamine chloride (3 mg/1) + Vitamin D (400 [iU]/1) + Zinc oxide (25 mg/1) + alpha-Tocopherol acetate (30 [iU]/1)TabletOralMission Pharmacal2010-02-01Not applicableUs

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
T66M6Y3KSA
CAS number
12298-68-9
InChI Key
DKNPRRRKHAEUMW-UHFFFAOYSA-N
InChI
InChI=1S/I3.K/c1-3-2;/q-1;+1
IUPAC Name
potassium triiodan-2-uide
SMILES
[K+].I[I-]I

References

General References
Not Available
KEGG Drug
D00860
KEGG Compound
C08040
ChemSpider
94785
RxNav
1376155
ChEBI
5948
Wikipedia
Lugol%27s_iodine

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Not Yet RecruitingDiagnosticEndoscopists'Subjective Assessments / Image Quality of Early Esophageal Squamous Neoplasia1
3TerminatedPreventionHeart Failure1
2CompletedScreeningImage Quality / Mucosal Irritation1
2TerminatedTreatmentNon-Hodgkin's Lymphoma (NHL)1
Not AvailableCompletedNot AvailableGraves Diseases1
Not AvailableRecruitingPreventionEsophageal Squamous Cell Neoplasm1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
TabletOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP2.04ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count0ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area0 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity40.02 m3·mol-1ChemAxon
Polarizability16.55 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on July 09, 2018 13:43 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates